Skip to content
★ Sign in to follow
ES

Elizabeth Stoner

Momenta Pharmaceuticals Inc
Total declarations
37
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (22 ops.)
€1.2M

Latest filing published 01 Oct 2020 for MOMENTA PHARMACEUTICALS INC.

Filing timeline

BuySale
Elizabeth Stoner

Insider track record

Disclosed buys
0
Disclosed sells
22
Signal history

Elizabeth Stoner: trading record in brief

Elizabeth Stoner discloses dealings in Momenta Pharmaceuticals Inc to SEC (Form 4). In total, 37 filings cover trades dated from 15 February 2011 to 1 October 2020.

Every open-market trade on record is a sale: 22 sales worth €1.2M. The rest of the record consists of 1 share grant and 13 option exercises. So far in 2020, the count stands at no purchases and 1 sale.

Most recently, on 1 October 2020, the filings show a transaction in Momenta Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Elizabeth Stoner

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations37 total

25 of 37 declarations